Search

A new oxidovanadium(V) complex, [VOL(OCH3)(CH3OH)] (1), was prepared from N'-(2-hydroxy-3-methoxybenzylidene)-3,5-dimethoxybenzohydrazide (H2L). Reaction of 1 with ethyl maltol (HL') in methanol afforded the new oxidovanadium(V) complex, [VOLL'] (2). The complexes were characterized by IR, UV and 1H NMR spectra. Structures of the complexes were further confirmed by single crystal X-ray determination. The V ions in the complexes are octahedral. The hydrazone ligands coordinate to V through the phenolate O, imino N, and enolate O. The ethyl maltolate ligand coordinates to V through the carbonyl and hydroxy oxygens. Both complexes show effective antibacterial activity against B. subtilis, S. aureus and P. aeruginosa. Thermogravimetric analysis was also performed. [ABSTRACT FROM AUTHOR]

Therapeutic outcome for the treatment of glioma was often limited due to the two barriers involved: the blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB). Therefore, the development of nanocarriers that possess both BBB and BBTB permeability and glioma-targeting ability is of great importance for the chemotherapy of glioma. New frontiers in nanomedicine are advancing the research of new biomaterials. Here we constructed a natural high-density lipoprotein particle (HDL)-based drug delivery system with the dual-modification of T7 and dA7R peptide ligand (T7/dA7R-HDL) to achieve the above goals. HDL, the smallest lipoprotein, plays a biological role and is highly suitable as a platform for delivering imaging and therapeutic agents. T7 is a seven-peptide ligand of transferrin receptors (TfR) capable of circumventing the BBB and then targeting glioma. dA7R is a D-peptide ligand of vascular endothelial growth factor receptor 2 (VEGFR 2) overexpressed on angiogenesis, presenting excellent glioma-homing property. 10-Hydroxycamptothecin (HCPT), a hydrophobic anti-cancer drug, was used as the model drug in this study. By combining the dual-targeting delivery effect, the dual-modified HDL displayed higher glioma localization than that of single ligand-modified HDL or free HCPT. After loading with HCPT, T7/dA7R-HDL showed the most favorable anti-glioma effect in vivo. These results demonstrated that the dual-targeting natural nanocarriers strategy provides a potential method for improving brain drug delivery and anti-glioma treatment efficacy. [ABSTRACT FROM AUTHOR]

A 2-D chiral entangled coordination polymer, {Mn3(2,2′-bpy)2(3-cpta)2·H2O}n (1) (3-H3cpta=3-(3′-carboxyphenoxy)phthalic acid, 2,2′-bpy=2,2′-bipyridine), has been synthesized via the solvothermal method. X-ray diffraction analysis reveals that 1 consists of one right-handed helical chain and one wavelike 2-D plane, which are connected with each other through hydrogen bonds and π···π interactions to generate a 3-D supra-molecule. Thermal gravimetric analysis shows that 1 possesses good thermal stability. Temperature dependent magnetic susceptibilities have also been measured from 1.8 to 300 K, which shows 1 to be anti-ferromagnetic. [ABSTRACT FROM AUTHOR]

Reactive oxygen species (ROS)-induced neuronal mitochondrial dysfunction is a key pathologic factor in sporadic Alzheimer's disease (AD). Neuronal mitochondria have been proposed to be a promising therapeutic target for AD, especially for the failures of phase III clinical trials on conventional amyloid-β (Aβ) targeted therapy. However, the efficient intravenous delivery of therapeutic agents to neuronal mitochondria in the brain remains a major challenge due to the complicated physiological environment. Recently, biomaterials-based nanomedicine has been widely investigated for the treatment of AD. Herein, we devised a strategy for functional antioxidant delivery to neuronal mitochondria by loading antioxidants into red blood cell (RBC) membrane-coated nanostructured lipid carriers (NLC) bearing rabies virus glycoprotein (RVG29) and triphenylphosphine cation (TPP) molecules attached to the RBC membrane surface (RVG/TPP NPs@RBCm). With the advantage of suitable physicochemical properties of NLC and unique biological functions of the RBC membrane, RVG/TPP NPs@RBCm are stabilized and enabled sustained drug release, providing improved biocompatibility and long-term circulation. Under the synergistic effects of RVG29 and TPP, RVG/TPP NPs@RBCm can not only penetrate the blood–brain barrier (BBB) but also target neuron cells and further localize in the mitochondria. After encapsulating Resveratrol (RSV) as the model antioxidant, the data demonstrated that RVG/TPP-RSV NPs@RBCm can relieve AD symptoms by mitigating Aβ-related mitochondrial oxidative stress both in vitro and in vivo. The memory impairment in APP/PS1 mice is significantly improved following the systemic administration of RVG/TPP-RSV NPs@RBCm. In conclusion, intravenous neuronal mitochondria-targeted dual-modified novel biomimetic nanosystems are a promising therapeutic candidate for ROS-induced mitochondrial dysfunction in AD. [ABSTRACT FROM AUTHOR]

Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature and low permeability of drugs across the blood-brain barrier (BBB). An ideal glioma-targeted delivery system need to traverse the BBB and then target glioma cells with adequate optimized physiochemical properties and biocompatibility. However, it is an enormous challenge to the researchers to engineer the above-mentioned features into a single nanocarrier particle. New frontiers in nanomedicine are advancing the research of new biomaterials. In this study, we demonstrate a strategy for glioma targeting by encapsulating vincristine sulfate (VCR) into a naturally available low-density lipoprotein particles (LDL)-based drug delivery system with the modification of T7 peptide ligand (T7-LDL). LDL, endogenous lipid transporters, can specifically bind to brain endothelial cells and glioma cells via interacting with the low-density lipoprotein receptors (LDLR). T7 is a seven-peptide ligand of transferrin receptors (TfR) capable of circumventing the BBB and then targeting glioma. By combining the dual-targeting delivery effect of T7 peptide and parent LDL, T7-LDL displayed higher glioma localization than that of parent LDL. After loading with VCR, T7-LDL showed the most favorable antiglioma effect in vitro and in vivo. These results demonstrated that T7-LDL is an important potential drug delivery system for glioma-targeted therapy. [ABSTRACT FROM AUTHOR]

Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross the BBB and BBTB and then target glioma cells with adequate optimized physiochemical properties and biocompatibility. However, it is an enormous challenge to the researchers to engineer the above-mentioned features into a single nanocarrier particle. New frontiers in nanomedicine are advancing the research of new biomaterials. In this study, we demonstrate a strategy for glioma targeting by encapsulating vincristine sulfate (VCR) into a naturally available apoferritin nanocage-based drug delivery system with the modification of GKRK peptide ligand (GKRK-APO). Apoferritin (APO), an endogenous nanosize spherical protein, can specifically bind to brain endothelial cells and glioma cells via interacting with the transferrin receptor 1 (TfR1). GKRK is a peptide ligand of heparan sulfate proteoglycan (HSPG) over-expressed on angiogenesis and glioma, presenting excellent glioma-homing property. By combining the dual-targeting delivery effect of GKRK peptide and parent APO, GKRK-APO displayed higher glioma localization than that of parent APO. After loading with VCR, GKRK-APO showed the most favorable antiglioma effect in vitro and in vivo. These results demonstrated that GKRK-APO is an important potential drug delivery system for glioma-targeted therapy. [ABSTRACT FROM AUTHOR]

The complete mitochondrial genome ofTambocerus sp.(Hemiptera: Cicadellidae) from Zhejiang and Anhui provinces of China was sequenced. The total length of the mitogenome is 15 955 bp (GenBank accession no. KT827824) and consists of 22 transfer RNAs, 13 protein-coding genes, 2 ribosomal RNAs and 1 control region. The base composition of the heavy strand for A, T, C, and G is 41.39, 35.02, 14.00, and 9.59%, respectively. All of the protein-coding genes (PCGs) start with ATN. Five protein-coding genes use TAA as stop codons, four use TAG as stop codons, and others use incomplete stop codons ‘‘T––’’ or ‘‘TA–’’. The control region has a length of 1581 bp which is betweenrrnSandtrnIgenes with the AT content high to 85.96%. Phylogenetic analysis indicated thatTambocerus sp.was clustered in a closely related subgroup withHomalodisca vitripennisandEmpoasca vitis. This is consistent with the result of the traditional taxonomy. [ABSTRACT FROM PUBLISHER]

The complete mitochondrial genome ofEmpoasca vitiswas sequenced. The length of the mitogenome is 15,154 bp with 78.35% AT content (GenBank accession No. KJ815009). The genome encode 37 typical mitochondrial genes including 22 transfer RNA genes, 13 protein-coding genes, 2 ribosomal RNA genes and an A+T-rich region. The gene arrangement is similar to that ofDrosophila yakuba, the presumed ancestral insect mitochondrial gene arrangement. Except forcox2using GTG as start codon, other protein-coding genes (PCGs) share the start codons ATN. Usual termination codon TAA and incomplete stop codon T are using by 13 protein-coding genes. The A+T-rich region has a length of 977 bp with the AT content high to 88.95%. [ABSTRACT FROM AUTHOR]

Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature and low permeability of drugs across the blood-brain barrier (BBB). An ideal glioma-targeted delivery system need to traverse the BBB and then target glioma cells with adequate optimized physiochemical properties and biocompatibility. However, it is an enormous challenge to the researchers to engineer the above-mentioned features into a single nanocarrier particle. New frontiers in nanomedicine are advancing the research of new biomaterials. In this study, we demonstrate a strategy for glioma targeting by encapsulating vincristine sulfate (VCR) into a naturally available low-density lipoprotein particles (LDL)-based drug delivery system with the modification of T7 peptide ligand (T7-LDL). LDL, endogenous lipid transporters, can specifically bind to brain endothelial cells and glioma cells via interacting with the low-density lipoprotein receptors (LDLR). T7 is a seven-peptide ligand of transferrin receptors (TfR) capable of circumventing the BBB and then targeting glioma. By combining the dual-targeting delivery effect of T7 peptide and parent LDL, T7-LDL displayed higher glioma localization than that of parent LDL. After loading with VCR, T7-LDL showed the most favorable antiglioma effect in vitro and in vivo. These results demonstrated that T7-LDL is an important potential drug delivery system for glioma-targeted therapy. [ABSTRACT FROM AUTHOR]

Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross the BBB and BBTB and then target glioma cells with adequate optimized physiochemical properties and biocompatibility. However, it is an enormous challenge to the researchers to engineer the above-mentioned features into a single nanocarrier particle. New frontiers in nanomedicine are advancing the research of new biomaterials. In this study, we demonstrate a strategy for glioma targeting by encapsulating vincristine sulfate (VCR) into a naturally available apoferritin nanocage-based drug delivery system with the modification of GKRK peptide ligand (GKRK-APO). Apoferritin (APO), an endogenous nanosize spherical protein, can specifically bind to brain endothelial cells and glioma cells via interacting with the transferrin receptor 1 (TfR1). GKRK is a peptide ligand of heparan sulfate proteoglycan (HSPG) over-expressed on angiogenesis and glioma, presenting excellent glioma-homing property. By combining the dual-targeting delivery effect of GKRK peptide and parent APO, GKRK-APO displayed higher glioma localization than that of parent APO. After loading with VCR, GKRK-APO showed the most favorable antiglioma effect in vitro and in vivo. These results demonstrated that GKRK-APO is an important potential drug delivery system for glioma-targeted therapy. [ABSTRACT FROM AUTHOR]

The fine particles are considered a significant pollution problem. The wet electrostatic precipitators (ESPs) have advantages of efficient collection of the fine particles with lower pressure drop and eliminating reentrainment. The wetting properties of the collector surfaces have significantly important effect on wet ESPs’ stable and secure operation. The modified rigid collector (MRC) was modified by coating specific vinyl ester resin composites and loose glass fiber cloth over the conventional carbon steel in a certain way. The rigid collector surfaces before and after modification had been characterized by scanning electron microscopy (SEM) and interface tensiometer. The effect of operating temperatures on the wetting properties of the rigid collector surfaces before and after modification was investigated. The temperature range was 40~90 °C, and the wetting properties contained liquid holdup, surface flow rate, film rate, average film thickness, and critical saturation time. The modified rigid collector surface exhibited excellent wetting properties at the operating temperatures. The fine particles collection performance compared among the MRC, the conventional rigid collector (CRC), and the flexible collector (FC) in the wet ESPs was investigated. The effects of the applied voltage, the water film, corona power, and the specific collecting area on the fine particles collection were evaluated. The modified rigid collector provided high fine particles collection effect with lower energy and water consumption. Implications: To improve the submicron particles collection efficiency and decrease energy and water consumption, the formation of uniform water film over the collector surfaces has been widely studied. The modified rigid collector was modified by coating specific vinyl ester resin composites and loose glass fiber cloth (ERGF) over the conventional carbon steel (CCS) in a certain way. The modified rigid collector surface exhibited excellent wetting properties. The wet ESPs by the modified rigid collector exhibited significantly higher particles collection efficiency than by the conventional rigid collector. [ABSTRACT FROM AUTHOR]

Three new complexes, {[Mn(dtb)(bpe)·2H2O]·H2O}n(1), {[Mn(dtb)(bpa)·2H2O]·H2O}n(2), and {[Mn(dtb)(phen)]}n(3) [H2dtb = 5,5′-dithiobis(2-nitrobenzoic acid), bpe = 1,2-bis(4-pyridyl)ethene, bpa = 1,2-bi(4-pyridyl)ethane, phen = 1,10-phenanthroline], have been synthesized under hydrothermal conditions with Mn(OAc)2·4H2O, dtb, and differentN-donor ligands. X-ray structure analyses of1and2reveal analogous structures with 1D helical chains and 2D 44chiral layers. The structure of3shows a 1D chain which is outwardly decorated with phen ligands. These neutral polymeric complexes exhibit structural diversity due to the different coordination modes of the flexible dtb ligand and the N-donor ligands. The thermogravimetric analyses and X-ray powder diffractions of1–3are also presented. [ABSTRACT FROM AUTHOR]

A new coordination polymer, {[Ag(H3bptc)(bpe)] · 2H2O} n (1) (H4bptc = 3,3′,4,4′-benzophenonetetracarboxylic acid, bpe = 1,2-bis(4-pyridyl)ethene), has been synthesized through a hydrothermal technique and structurally characterized. The crystal structure of 1 exhibits a 2-D hydrogen-bonding sheet between H3bptc− and two free water molecules. Fluorescent property, TG analysis, and X-ray powder diffraction for 1 were also measured and discussed. [ABSTRACT FROM AUTHOR]

This work investigated the cytotoxicities of three silver nanoparticles (SNPs) SNP-5, SNP-20 and SNP-50 with different sizes (∼ 5 nm, ∼ 20 nm and ∼ 50 nm) using four human cell models (A549, SGC-7901, HepG2 and MCF-7). Endpoints included cell morphology, cell viability, cellular membrane integrity, oxidative stress and cell cycle progression. Observable deleterious effects on the cell morphologies and membrane integrity were induced by SNP-5 and SNP-20. SNPs elevated the ROS levels in cells and arrested the cells at S phase. Apoptosis occurred for 4–9% of the exposed cells. All these cellular responses as well as EC50 values were found to be size-dependent for the tested SNPs. Ultrastructural observations confirmed the presence of SNPs inside cells. Elemental analysis of silver in cells by ICP-MS showed that smaller nanoparticles enter cells more easily than larger ones, which may be the cause of higher toxic effects. The findings may assist in the design of SNP applications and provide insights into their toxicity. [ABSTRACT FROM AUTHOR]

The effects of phenylethyl isothiocyanate (PEITC) on urinary bladder and liver carcinogenesis were analyzed in a rat model. Diets containing 0.1%, 0.05%, or 0.01% PEITC were administered for 32 wk to male Fischer 344 rats with and without pretreatment with an injection of diethylnitrosamine (200 mg/kg body wt ip) and 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine in the drinking water for 4 wk for initiation. In the initiated groups, PEITC administration significantly increased the incidences of papillary or nodular hyperplasia, dysplasia, and transitional cell carcinomas at higher doses of 0.01%, 0.01%, and 0.05%, respectively, compared with the control group, given initiation alone, in a dose-dependent manner. Without initiation, administration of 0.1% and 0.05% PEITC induced simple and papillary or nodular hyperplasia and dysplasia in the urinary bladder. In the liver, induction of glutathione S-transferase placental form-positive foci was dose dependently enhanced by PEITC administration, but the incidences of liver tumors were not different among the groups. From the present experiment, we can conclude that >0.01% PEITC enhances rat urinary bladder carcinogenesis, while weakly promoting hepatocarcinogenesis. In addition, it is suggested that >0.05% PEITC has tumorigenic potential. [ABSTRACT FROM AUTHOR]